Satisfaction and Compliance of Risedronate in PMO

计划入组 202 人 · 首次发布于 2007 年 10 月 26 日

CRAFT: The NCT-PMO-1602 Phase II Trial

计划入组 72 人 · 首次发布于 2020 年 9 月 16 日

Efficacy and Safety of MW031 in PMO Subjects

计划入组 448 人 · 首次发布于 2022 年 1 月 31 日

PMO-25

Pip6a-PMO

M12-PMO

PMV Pharmaceuticals

United States

PRO-IMPLANT Foundation

Germany

AMO Pharma Ltd.

United Kingdom

MustardSeed Launches UK Operations to Support Life Sciences and Advanced Manufacturing Sectors Under Britain's Modern Industrial Strategy

Sarepta's ESSENCE Study Shows Mixed Results for Duchenne Muscular Dystrophy Therapies Despite Missing Primary Endpoint

Capricor Therapeutics Advances Exosome Drug Delivery with Scalable Manufacturing Framework